CytoGuide ApS |
 |
Concept Development |
Lead Discovery |
Lead Optimization |
Preclinical Development |
Phase I |
Phase II |
Phase III |
Launch |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Project: CD163 |
|
||||||||||||||||
CytoGuide is developing therapies for treating inflammatory diseases. A humanized antibody conjugate has been produced and proof-of-concept has been reached in animal models for the technology. The platform technology will be used to develop drugs for the treatment of a range of diseases where macrophages are involved.
| Contact: Søren Moestrup, CEO | +45 289 922 82| skm@cytoguide.dk | www.cytoguide.dk |